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INTRODuCTION
Stress urinary incontinence (SUI) is a high 
prevalent condition with great economic and qual-
ity of life impact (1). Loss of adequate anatomic 
urethral support and intrinsic sphincter deficiency 
(ISD) are the two major components related to the 
development of stress urinary incontinence (SUI). 
Surgical techniques are effective to repair the ana-
tomic support defect. However, the treatment of 
ISD component is a much more complex issue. 
The intrinsic sphincter accounts for approximately 
50% of the continence mechanism and inconti-
nence occurs as a consequence of  decreased ac-
tivity of the smooth muscle of the intrinsic urethra.
 In the past, different approaches have been 
described to improve the urethral continence. One 
minimally invasive alternative was the injection 
of bulking agents (2). Several materials were tested 
with different success rates (3,4). However, none 
of them sustained significant results according to 
time (5). The lack of an ideal substance to use as 
bulking agent and the potential to urethral func-
tion regeneration by means of cell therapy and 
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tissue engineering lead to studies based on cells 
transplantation into the urethral wall and rhab-
dosphincter (6-8). However, such therapies are as-
sociated with major potential risks that should be 
extensively evaluated before clinical application.
 One of the biggest challenges to develop 
new SUI treatments is the lack of an ideal animal 
model to test such treatments. This is particularly 
true when planning to develop a successful cell 
transplantation therapy for a non life-threating 
disease. An animal model to test cell injections 
should allow: reproducible injection in an ade-
quate thick urethral wall, an easy and reproduc-
ible evaluation of functional and morphological 
regeneration/recuperation, an autologous trans-
plantation, a mid and long term follow-up and 
the evaluation of possible cell migration teratoge-
nicity and mutagenicity.
The majority of SUI animal models were 
developed in rats. However, low bladder capacity, 
presence of early detrusor contraction, small ure-
thral wall thickness and small diameter make the 
cells injections and functional analysis of such 
animals very complicated with several possible 
biases. Furthermore, the urethral cell injections 
described in the literature (9) were performed ei-
ther with isogenic or immunossupressed animals 
and it is much more feasible to perform autolo-
gous cell transplantation in rabbits than in rats. 
On the other hand, rabbits are bigger animals, 
with larger bladder capacity, shorter relative func-
tional urethra, thicker urethra wall, larger urethral 
lumen, stable bladder and allow autologous cells 
transplantation. In the present study, we exam-
ined the possibility to develop a urethral sphincter 
deficiency animal model in rabbits that would be 
suitable for the study of urethral cell injections.
MATERIALs AND METHODs
The present study was conducted after ap-
proval and following all requirements from the 
Ethical Committee of our institutions.
Developing urinary incontinence model
After the initial evaluation, a total of 40 
new Zealand male rabbits, weighting 2.500 kg to 
3.100 kg were used to develop an incontinent ani-
mal model to test cell therapy.
 The study was designed to determine if 
a standardized peri-urethral lesion (urethrolysis) 
would determine urethral functional and morpho-
logical changes, as previously described in rats 
(10). Thirty two animals underwent urethrolysis 
and 8 rabbits were kept as a sham group. Animals 
underwent cystometry and LPP determination, 
before surgical procedure and at 2, 4, 8 and 12 
weeks after intervention. In each of the previous 
mentioned time point, 10 animals (8 animals from 
the study group and 2 animals from the sham 
group) were sacrificed to harvest the bladder and 
urethra.
Anesthesia, analgesics and antibiotic prophylaxis
 For the cystometric and LPP evaluation, 
the rabbits were anesthetized using 20 mg/kg of 
intramuscular (IM) Ketamine, 10 minutes prior 
the study. Transabdominal urethrolysis was per-
formed after the first cystometric evaluation, us-
ing 4 mg/kg of additional intramuscular Xylazine. 
Whenever necessary, we used a maintenance dose 
of 5 mg/kg of Ketamine and 1 mg/kg of Xylazine 
(IM) during the surgical procedure.
 Antimicrobial prophylaxis was carried out 
with 100 mg of sodium Cefalotine (IM), in a single 
dose, one hour before the surgery. Postoperative 
analgesia was carried out with 100 mg of sodium 
Dipirona (IM), every 8 hours, for 2 days.
 To harvest bladder and urethra, the ani-
mals were anesthetized similarly to the urethroly-
sis, being sacrificed by an intravenous high anes-
thetic dose.
Cystometric evaluation and LPP determination
A 4 Fr. catheter was placed inside the blad-
der through the urethra. The bladder was emptied 
and the catheter was connected to a three-way 
stopcock that allowed connection to the infusion 
pump (Harvard Apparatus model P-22) and to the 
pressure transducer (Viotti 5600/ Urosystem DS-
5600 version 4.52- Viotti & Assoc. - Sao Paulo - 
Brazil). The bladder was filled out at a continuous 
rate of 3 ml per minute (about 10% of the blad-
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der capacity), with methylene blue diluted in sa-
line (1:1000) to facilitate determination of urinary 
leakage (10). The bladder capacity was determined 
by filling it out until bladder contraction and mic-
turition ocurred.
 During the filling phase, abdominal pres-
sure was slowly increased by gentle and continu-
ous pressure with 2 fingers placed on the lower 
abdomen directly over the bladder until one drop 
was observed through urethral meatus (10). As 
soon as the leak was observed, the pressure was 
withdrawed and the bladder pressure rapidly re-
turned to baseline, demonstrating that leakage 
was not associated to  bladder contraction.
The pressure in the bladder at the exact 
moment that a drop was visualized on the ure-
thral meatus was considered as LPP. This measure 
was performed three times (the average value 
was used to statistical analysis) in three different 
moments of the filling phase; after infusion of 
10, 20, and 30 mL.
Transabdominal urethrolysis
 The urethrolysis was performed as previ-
ous described in rats (10). Briefly, after anesthesia 
and adequate antiseptic preparation, a suprapubic 
midline incision of 4 cm was performed in order to 
expose the bladder urethra. In the sham group, the 
incision was closed after complete exposure of the 
bladder and urethra. To perform the urethrolysis, 
we identified the ureter bilaterally and carried out 
the dissection of the entire urethra. Careful was 
taken to avoid vesical arteries and ureteral injury. 
To totally release the urethra, we opened the en-
dopelvic fascia and sectioned the pubic-urethral 
ligaments on both sides, dissecting the urethra cir-
cumferentially from its proximal to its distal point. 
The incision was closed in 2 separated layers using 
Vycril 4.0 in the abdominal wall and nylon 4.0 in 
the skin.
Histological analysis
After 2, 4, 8 and 12 weeks, the animals 
were sacrificed, the urethra and bladder were for-
malin fixed, paraffin embedded and cross-sec-
tioned in 5 μm sections. The slides were stained 
with Hematoxilin-Eosin (H&E) and Masson’s Tri-
chrome. Stereologic evaluation was performed to 
evaluate collagen and smooth muscle fibers den-
sity. Stereology is a method that uses systematic 
and randomized samples, counting the collagen 
and smooth muscle fibers density. The collagen 
and smooth muscle fibers were analyzed and 
counted in 100 random sterology microscopi-
cal fields under great magnification (400 X), of 
the urethra cross-section for each animal using 
Olympus microscope BX-51, with differential in-
terference contrast. Only one person analyzed the 
histological slides.
Statistics evaluation
The results were analyzed considering the 
type, distribution and nature of the variables using 
parametric or nonparametric tests. It was applied 
the Wilcoxon’s or Friedman’s analysis of variance 
to compare pre and postoperatively LPP values 
in different timepoints for each animal. The ste-
reological data were evaluated by Kruskal-Wallis’ 
test. Statistical significance was determined at p 
values < 0.05.
REsuLTs
The average functional bladder capacity 
pre and 12 weeks post urethrolysis was 34.5 ± 6.4 
mL and 36.2 ± 7.4 mL, respectively (p = 0.185). 
After urethrolysis, there was a progressive de-
crease in the ALPP. It becomes more evident with 
significant decrease (p < 0.05) at 2 weeks after 
urethrolysis (Figure-1). The pre and post urethrol-
ysis LPP evaluation with different bladder disten-
sion and at different time points are shown in 
Figure-1. The bladder volume did not interfere in 
the LPP value as shown in Figure-1. There was no 
significant difference between the control groups 
at various stages of study (Figure-1).
At 4 weeks, the LPP was similar to the 
LPP at 8 and 12 weeks (p > 0.05 - Figure-1). In 
the same way, there was a progressive increase 
in collagen and decrease in smooth muscle in the 
urethra wall. The control group presented un-
changed collagen/smooth muscle distribution in 
the urethra wall. The animals submitted to ure-
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Figure 1 – Average ALPP after filling the bladder with 10, 20 and 30 mL at different timepoints: pre-urethrolysis 2,4,8 and 
12 weeks after urethrolysis. sham group with 20 ml bladder distension
*p<0,05 – Compared with Sham group.
throlysis developed an increase in collagen and 
decrease in smooth muscle distribution that be-
came evident after 2 weeks (Figure-2 - p < 0.05). 
Figure-3 shows a Masson´s Tricrome staining at 
the different time points.
DIsCussION
The main purpose of the present study 
was to develop a durable and easily reproducible 
animal model that would allow testing autolo-
gous cellular therapy injection in the urethra wall. 
Rabbits allow autologous cell harvesting, have 
good endurance on surgery, a thick urethra wall, 
stable bladder and a good bladder capacity. Thus, 
we developed a functional and anatomical ure-
thral sphincter lesion in male rabbits. This animal 
model was demonstrated to be durable and eas-
ily reproducible. By performing urethrolysis, we 
created a functional damage demonstrated by a 
progressive and sustainable decrease in the LPP 
that was associated with decrease in urethral mus-
culature density.
 Several methods, which mimic a variety 
of clinical urodynamic tests, have been developed 
to determine urethral resistance in animal mod-
els of SUI. The majority of animal models were 
developed in rats. One of the most used methods 
to evaluate urethral resistance in rats is the deter-
mination of LPP (11). In these animal models, the 
intravesical pressure can be evaluated by urethral 
or suprapubic catheter (12,13). However, to deter-
mine the LPP in rats requires a very well trained 
investigator to eliminate confounding variables, 
especially because the LPP evaluation can trigger 
micturition and urethral catheter may increase the 
urethral resistance (14).
 In 1998, an animal model for SUI was 
developed in the attempt to simulate one of the 
known risk factors for the development of SUI. The 
authors used an intra-vaginal balloon to simulate 
birth vaginal trauma with or without ooforectomy 
(15,16). However, it was not effective in create a 
reproducible method. LPP decreases to approxi-
mately 60% of control values 4 days after sim-
ulated birth injury (17). When incontinence was 
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Figure 2 - Muscle and collagen distribuition (%) in the wall at different time points.
Figure 3 - Masson´s Tricrome staining at the different time points (Magnification = 400x).
PO = post operative in each timepoint - 2, 4, 8 and 12 weeks.
* Kruskal Wallis – p< 0.05 – compared with control group.
 A = Control Group at 8 weeks; B =2 weeks; C = 4 weeks; D = 8 weeks after urethrolysis.
Stained in red = muscle. 
Stained in purple = collagen and elastin.
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determined by a positive sneeze test performed 4 
weeks following vaginal distension, only one third 
of the rats were incontinent (15). In the present 
study, we observed an easily reproducible periure-
thral lesion. Once we standardized the periurethral 
lesion technique, all animals developed a signifi-
cant and consistent decrease in LPP.
 Another method described to determine 
urethral resistance in rodents is the tilting table 
test (18). The rat is mounted on a vertical tilting 
table to simulate the orientation of the human pel-
vis with respect to gravity and the spinal cord of 
the rat is transected at the T8-T9 level to eliminate 
bladder interference, while maintaining the ure-
thral closure mechanisms intact (18).
 Other studies with female rats were de-
scribed injuring  the pudendal nerve (19). The 
main problem with pudendal nerve crush models 
is that they create a recoverable localized dener-
vation of the striated muscle component and the 
whole pudendal innervation. To study stem cells 
effect on urethra, the urethral lesions should not 
heal spontaneously, because we need long term 
follow-up. In addition, it should include the stri-
ated and smooth urethral sphincter component to 
better reproduce the clinical aspects.
 In 2004, an animal model of intrinsic 
sphincter dysfunction has been described by elec-
trocoagulation of the urethral surrounding tissues 
(20); this model created a long lasting decrease 
in urethral resistance and more significant tis-
sue damage than childbirth simulations. Another 
study developed a urethral damage by perform-
ing a transabdominal urethrolysis in female rats. 
The authors observed a significant decrease in LPP 
and retrograde urethral perfusion pressure up to 
24 weeks. An histological analysis demonstrated a 
reduction of muscle fibers and an increase of the 
conjunctive tissue (10). In our study, we performed 
a similar intervention in rabbits confirming that 
such intervention can consistently decrease LPP 
associated with histological urethral changes.
 Few studies were performed in rabbits in 
order to develop a urinary incontinence animal 
model. In a work with male rabbits, after section-
ing the pudendal nerve bilaterally, it was observed 
a decrease in urethral resistance. However, after 
12 weeks, there was a recovery of the urethral 
occlusion pressure. The authors hypothesized a 
probable spontaneous regeneration of the nervous 
tissue (21).
 The main reason to develop an animal 
model is to allow safety tests before human use. 
In the past years, it has been proposed cell therapy 
injection as an alternative for urinary inconti-
nence treatment. Human use has been described 
based mainly on tests performed in isogenic or 
imunocompromised rats (9). We believe that such 
therapy should be tested using autologous cell 
transplantation before human use. The lack of uri-
nary incontinence animal model that allows au-
tologous cell harvesting restricts such tests. Our 
animal model can test autologous cellular therapy 
injection in the urethra wall.
 The major difficulty to create a urinary 
incontinent animal model is related to function-
al-anatomic characteristics that distinguish man 
from other animals. This difficulty in getting an 
animal model has led to surgical approaches and 
therapies for humans without being suitably tested 
in animal trials. The mostly used urinary inconti-
nence and sphincter deficiency animal models to 
test injectable cell therapy have been developed 
in female rats. The main problems with the use of 
such animals are: the difficulty to perform autolo-
gous tests, the high regenerative capacity leading 
to recovery of the urethral function after a certain 
period of time, the small bladder capacity (around 
1.5 mL), difficulty to determine the leak pressure 
due to bladder interference (bladder contraction 
during functional evaluation), a relatively longer 
urethral length with a small diameter and thin 
wall.
 Rabbits present reasonable anesthetic-sur-
gical resistance, allowing multiple surgical inter-
ventions and autologous cell harvesting; present a 
urethral wall with good thickness, allowing repro-
ductible and precise injections during cell therapy 
tests. We found that female new Zealand rabbits 
present a hypospadic urethral meatus. Thus, the 
urethral catheterization is an extreme challenging 
job. We designed a vaginoplasty in order to reach 
the meatus. nevertheless, the urethral catheteriza-
tion still was challenging and sometimes it could 
not be reproducible. We also performed a supra-
pubic vesical catheterization trying to accomplish 
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the cystosmetic evaluation and LPP determina-
tion. However, it changed the bladder behavior, 
created inflammation on the puncture spot and 
generated bladder leakage during LPP evaluation. 
One can criticize an animal model in male rabbits, 
as the majority of patients with stress urinary in-
continence are women. However, we were looking 
for a reproducible animal model that would allow 
testing safely and efficiently autologous cells in-
jections into the urethra wall. Furthermore, it has 
been described autologous muscle derived from 
stem cells in the human male urethra, without an 
extensive animal study (6).
 Despite interesting initial clinical out-
comes in SUI treatment using cell therapy, we 
need more basic research to clearly demonstrate 
safety for human use. The potential risks, such 
as teratogenicity, cell migration and mutagenic-
ity should be better evaluated, especially when 
treating a benign, non-life threating disease. The 
present animal model is a new alternative to test 
safely and effectively cell therapy to treat stress 
urinary incontinence. It also has the possibility to 
test autologous cell therapy as one alternative to 
functional and anatomical regeneration in a ure-
thral intrinsic sphincter deficiency animal model.
CONCLusIONs
Transabdominal urethrolysis created 
sphincteric insufficiency in rabbits with signifi-
cant decrease in the LPP associated with decrease 
of smooth muscle fibers and increase of collagen 
density. This animal model can be used to test au-
tologous cell therapy for stress urinary inconti-
nence treatment.
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